RCM
CRXTW

Radcliffe Capital Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Radcliffe Capital Management’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-70,893
Closed -$371K – 1122
2021
Q3 		$371K Sell
70,893
-154,107
-68% -$806K 0.01% 848
2021
Q2 		$2.27M Hold
225,000
– – 0.07% 442
2021
Q1 		$2.27M Buy
+225,000
New +$2.27M 0.09% 390